ConductScience.org, home

Paper6470977

Role of the gut flora in the reduction of sulfinpyrazone in humans.

Strong HA and 4 others. J Pharmacol Exp Ther, 1984. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Role of the gut flora in the reduction of sulfinpyrazone in humans. Papers, record 6470977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6470977

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of the gut flora in the reduction of sulfinpyrazone in humans.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.51
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Strong HAH A
2Oates JJ
3Sembi JJ
4Renwick AGA G
5George CFC F

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Digestive SystemMajor topic
SulfinpyrazoneMajor topic
Administration, Oral
Adult
Biological Availability
Enterobacteriaceae
Feces
Female
Half-Life
Humans
Ileostomy
Kinetics
Male
Metoclopramide
Middle Aged
Sulfides

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42148403
Scientific Opinion on Flavouring Group Evaluation 8, Revision 3 (FGE.08Rev3): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30.
EFSA J2011https://conductscience.org/library/papers/42148403PubMed
42079543Flavouring Group Evaluation 08 Rev2 (FGE.08 Rev2): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30.EFSA J2010https://conductscience.org/library/papers/42079543PubMed
42016132
Scientific Opinion on Flavouring Group Evaluation 08, Revision 5 (FGE.08Rev5): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30.
EFSA J2012https://conductscience.org/library/papers/42016132PubMed
42005759
Flavouring Group Evaluation 8, Revision 1 (FGE.08Rev1): Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without additional oxygenated functional groups from chemical groups 20 and 30.
EFSA J2010https://conductscience.org/library/papers/42005759PubMed
41017122Pharmacomicrobiomics.Clin Pharmacol Ther2025https://conductscience.org/library/papers/41017122PubMed
24271526Pharmacokinetics and Reversible Biotransformation of Sulfinpyrazone and Its Metabolites in Rabbits. II. Multiple-Dose Study.Pharm Res1986https://conductscience.org/library/papers/24271526PubMed
24271525Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits. I. Single-dose study.Pharm Res1986https://conductscience.org/library/papers/24271525PubMed
23343017Intestinal transport as a potential determinant of drug bioavailability.Curr Clin Pharmacol2013https://conductscience.org/library/papers/23343017PubMed
3816927Renal clearance of sulphinpyrazone in man.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3816927PubMed
3780113Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone.Clin Pharmacokinet1986https://conductscience.org/library/papers/3780113PubMed
2686883Clinical pharmacokinetic considerations in the elderly. An update.Clin Pharmacokinet1989https://conductscience.org/library/papers/2686883PubMed
2686738Prodrugs.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2686738PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6470977

GET https://conductscience.org/api/papers/v1/6470977/authors